These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15285333)

  • 1. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems.
    Tashtoush BM; Al-Qashi ZS; Najib NM
    Drug Dev Ind Pharm; 2004 Jul; 30(6):601-7. PubMed ID: 15285333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of two oral formulations of glyburide (glibenclamide).
    Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
    Proc West Pharmacol Soc; 2007; 50():64-6. PubMed ID: 18605232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the in-vitro dissolution and in-vivo oral bioavailability of silymarin from liquid-filled hard gelatin capsules of semisolid dispersion using Gelucire 44/14 as a carrier.
    Hussein A; El-Menshawe S; Afouna M
    Pharmazie; 2012 Mar; 67(3):209-14. PubMed ID: 22530301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
    Asyarie S; Rachmawati H
    PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique.
    Valleri M; Mura P; Maestrelli F; Cirri M; Ballerini R
    Drug Dev Ind Pharm; 2004 May; 30(5):525-34. PubMed ID: 15244088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Pharmacol; 2000 Jul; 52(7):831-8. PubMed ID: 10933133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems.
    Pan RN; Chen JH; Chen RR
    Drug Dev Ind Pharm; 2000 Sep; 26(9):989-94. PubMed ID: 10914324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide.
    Hong SS; Lee SH; Lee YJ; Chung SJ; Lee MH; Shim CK
    J Control Release; 1998 Feb; 51(2-3):185-92. PubMed ID: 9685916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
    Zoeller T; Dressman JB; Klein S
    Int J Pharm; 2012 Jul; 430(1-2):176-83. PubMed ID: 22531855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide.
    Chalk JB; Patterson M; Smith MT; Eadie MJ
    Eur J Clin Pharmacol; 1986; 31(2):177-82. PubMed ID: 3100314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pharmacokinetics and pharmacodynamics of two commercial products containing glibenclamide.
    el-Sayed YM; Suleiman MS; Hasan MM; Abdel-Hamid ME; Najib NM; Sallam ES; Shubair MS
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):551-7. PubMed ID: 2515159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants.
    Cirri M; Maestrelli F; Corti G; Mura P; Valleri M
    Drug Deliv; 2007 Apr; 14(4):247-55. PubMed ID: 17497357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
    Soliman MS; Khan MA
    Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of fast release glibenclamide liquid and semi-solid matrix filled capsules.
    Galal S; El-Massik M; Abdallah O; Daabis N
    Acta Pharm; 2003 Mar; 53(1):57-64. PubMed ID: 14769253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole.
    Heo MY; Piao ZZ; Kim TW; Cao QR; Kim A; Lee BJ
    Arch Pharm Res; 2005 May; 28(5):604-11. PubMed ID: 15974450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.
    Yüksel N; Karataş A; Ozkan Y; Savaşer A; Ozkan SA; Baykara T
    Eur J Pharm Biopharm; 2003 Nov; 56(3):453-9. PubMed ID: 14602190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
    El-Maghraby GM; Alomrani AH
    Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.